A Study of DC05F01 in Chinese Patients with Recurrent/Refractory Ovarian Cancer and Other Advanced Solid Tumors

PHASE1/PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 11, 2024

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions

Solid TumorsOvarian CancerSmall Cell Lung Cancer

Interventions

DRUG

DC05F01

DC05F01 capsule

Trial Locations (2)

RECRUITING

The Fisrt Affiliated Hospital of Bengbu Medical University, Bengbu

RECRUITING

Hunan Cancer Hospital, Changsha